Trials
TUSTIN, CA: Contract Manufacturing Revenue Expected to Exceed $18 Million for Fiscal Year 2013; Company Reaches Agreement With FDA on Pivotal Phase III Clinical Trial Design for Cotara; Multiple Bavituximab Clini ...
BOSTON, MA: WCC President Rick Walovitch to Present on Central Review for Trials With Subjective Endpoints at CBI Bio/Pharmaceutical Imaging Forum on December 11th
...
BOSTON, MA: Leverages Established Clinical Infrastructure to Facilitate Real-Time Global Site Support
...
ATLANTA, GA: Special Track for Principal Investigators Offers CME Credits
...
NEW YORK, NY: Study Demonstrated Desirable Pharmacokinetic Profile With Rapid Absorption Well-Suited for Bedtime Use
...
TUSTIN, CA: Company Replaces Prior Loan Facility With Over $14 Million in Financing Proceeds Received Since September 27th; Growing Contract Manufacturing Business Remains on Track for Record Revenue Year; Multip ...
MANCHESTER, NH: Initiated launch of SUGARDOWN(R) in the U.S. at the Endocrinology Annual Meeting; SUGARDOWN(R) Sales Increased 845% in the First Half of 2012; Completed Patient Enrollment for Phase II PAZ320 Clinical ...
CAMBRIDGE, MA: Webcast Accessible via Sarepta Therapeutics Website
...
